Clinical Trial Update: Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing capsule and liquid formulations of enzalutamide after a single dose under fasting conditions in prostate cancer was terminated; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED | Results posted: 2021-05-10